Note 3 - Discontinued Operations (Details) (USD $)	9 Months Ended						3 Months Ended
	Sep. 30, 2013	Sep. 30, 2013 Strategic Services Operating Division [Member]	Sep. 30, 2013 Strategic Services Operating Division [Member] Minimum [Member]	Sep. 30, 2013 Strategic Services Operating Division [Member] Maximum [Member]	Sep. 30, 2013 Pharmalicensing, Global Licensing, Pharma Transfer, and Knowledge Express [Member] IP Tech Ex [Member]	Sep. 30, 2013 Pharmalicensing, Global Licensing, Pharma Transfer, and Knowledge Express [Member]	Mar. 31, 2013 IP Tech Ex [Member]	Sep. 30, 2013 IP Tech Ex [Member]
Note 3 - Discontinued Operations (Details) [Line Items]
Sale Price For Sale Of Business Or Division Of Company						$ 2,000,000
Cash Received Upon Closing						600,000
Debt Assumed						70,000
Quarterly Payment					100,000
Reduction In Purchase Price Of Discontinued Operations Payment					125,000
Note Receivable Interest Rate					5.00%
Note Receivable Expected Payment Receipt								400,000
Note Receivable Remaining Amount After Expected Payment Consider								300,000
Loss on write-down of note receivable	593,437						489,000
Note Receivable Expected Realizable Value							700,000
Assets Primarily Intellectual Property Rights And Equipment To Be Sold As Per Purchase Agreement		100,000
Bonuses Agreed To Be Forgone By Officers And Employees As Per Agreement		1,489,000
Amount To Be Paid In Exchange Of Bonuses Owed To Officers And Employees		150,000
Percentage Of Professional Fees In Excess Of Specified Amount As Royalty To Be Received As Per Agreement		12.50%
Amount Of Professional Revenue Earned Used For Computing Royalty		$ 10,000,000
Period of professional revenue earned used for computing royalty			Oct. 02, 2012	Dec. 31, 2015